The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation. Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society

Atherosclerosis

Volumn 241, Issue 2, 2015, Pages 507-532

  Vlachopoulos, Charalambos ^a   Xaplanteris, Panagiotis ^a   Aboyans, Victor ^b   Brodmann, Marianne ^c   Cífková, Renata ^d   Cosentino, Francesco ^e   De Carlo, Marco ^f   Gallino, Augusto ^g   Landmesser, Ulf ^h   Laurent, Stéphane ⁱ   Lekakis, John ^a   Mikhailidis, Dimitri P ^j   Naka, Katerina K ^k   Protogerou, Athanasios D ^l   Rizzoni, Damiano ^m   Schmidt Trucksäss, Arno ⁿ   Van Bortel, Luc ^o   Weber, Thomas ^p   Yamashina, Akira ^q   Zimlichman, Reuven ^r   Boutouyrie, Pierre ⁱ   Cockcroft, John ^s   O'Rourke, Michael ^t   Park, Jeong Bae ^u   Schillaci, Giuseppe ^v   Sillesen, Henrik ^w   Townsend, Raymond R ^x   more..

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITAL GRAZ   (Austria)

^d CHARLES UNIVERSITY   (Czech Republic)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f CISANELLO HOSPITAL   (Italy)

^g OSPEDALE SAN GIOVANNI   (Switzerland)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^j ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^k UNIVERSITY OF IOANNINA   (Greece)

^l UNIVERSITY OF ATHENS   (Greece)

^m UNIVERSITY OF BRESCIA   (Italy)

ⁿ UNIVERSITY OF BASEL   (Switzerland)

^o GHENT UNIVERSITY   (Belgium)

^p Klinikum Wels Grieskirchen GmbH   (Austria)

^q TOKYO MEDICAL UNIVERSITY   (Japan)

^r TEL AVIV UNIVERSITY   (Israel)

^s CARDIFF UNIVERSITY   (United Kingdom)

^t UNIVERSITY OF NEW SOUTH WALES   (Australia)

^u Dankook University College of Medicine   (South Korea)

^v UNIVERSITY OF PERUGIA   (Italy)

^w UNIVERSITY OF COPENHAGEN   (Denmark)

^x UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

Ankle brachial index; Arterial stiffness; Carotid ultrasonography; Central haemodynamics; Circulating biomarkers; Endothelial function; Vascular biomarkers; Wave reflections

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

AGING; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; BRACHIAL ANKLE PULSE WAVE VELOCITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CAROTID ATHEROSCLEROSIS; CAROTID FEMORAL PULSE WAVE VELOCITY; DYSLIPIDEMIA; ECHOGRAPHY; HEART HEMODYNAMICS; HUMAN; HYPERTENSION; MEDICAL SOCIETY; MICROANGIOPATHY; PERIPHERAL ARTERIAL TONOMETRY; PERIPHERAL CIRCULATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIMARY PREVENTION; PRIORITY JOURNAL; PULSE WAVE; REVIEW; SECONDARY PREVENTION; ARTERIAL WALL THICKNESS; BLOOD; CARDIOLOGY; CARDIOVASCULAR DISEASES; CAROTID ARTERY; COST BENEFIT ANALYSIS; DECISION MAKING; EUROPE; HEMODYNAMICS; METABOLISM; METHODOLOGY; RISK; STANDARDS; TREATMENT OUTCOME;

AGING; ANKLE BRACHIAL INDEX; BIOMARKERS; C-REACTIVE PROTEIN; CARDIOLOGY; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; COST-BENEFIT ANALYSIS; DECISION MAKING; EUROPE; HEMODYNAMICS; HUMANS; PRIMARY PREVENTION; RESEARCH DESIGN; RISK; SECONDARY PREVENTION; SOCIETIES, MEDICAL; TREATMENT OUTCOME; ULTRASONOGRAPHY; VASCULAR STIFFNESS;

EID: 84937126409     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.05.007     Document Type: Review

References (299)

1. Conroy R.M., Pyorala K., Fitzgerald A.P., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart J. 2003, 24:987-1003.
2. At). http://www.framinghamheartstudy.org/.
3. Goff D.C., Lloyd-Jones D.M., Bennett G., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the american college of Cardiology/American heart association task force on practice guidelines. J.Am. Coll. Cardiol. 2014, 63(25 Pt B):2935-2959.
4. Siontis G.C., Tzoulaki I., Siontis K.C., Ioannidis J.P. Comparisons of established risk prediction models for cardiovascular disease: systematic review. BMJ 2012, 344:e3318.
5. Cooney M.T., Dudina A.L., Graham I.M. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J.Am. Coll. Cardiol. 2009, 54:1209-1227.
6. Biomarkers Definitions Working G Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 2001, 69:89-95.
7. Hlatky M.A., Greenland P., Arnett D.K., et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009, 119:2408-2416.
8. Nilsson P.M., Boutouyrie P., Laurent S. Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension 2009, 54:3-10.
9. Touboul P.J., Hennerici M.G., Meairs S., et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc. Dis. 2012, 34:290-296.
10. Stein J.H., Korcarz C.E., Hurst R.T., et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J.Am. Soc. Echocardiogr. 2008, 21:93-111. Quiz 89-90.
11. O'Leary D.H., Polak J.F., Wolfson S.K., et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 1991, 22:1155-1163.
12. Espeland M.A., Hoen H., Byington R., Howard G., Riley W.A., Furberg C.D. Spatial distribution of carotid intimal-medial thickness as measured by B-mode ultrasonography. Stroke 1994, 25:1812-1819.
13. Montauban van Swijndregt A.D., De Lange E.E., De Groot E., Ackerstaff R.G. An invivo evaluation of the reproducibility of intima-media thickness measurements of the carotid artery segments using B-mode ultrasound. Ultrasound Med. Biol. 1999, 25:323-330.
14. Riley W.A., Barnes R.W., Applegate W.B., et al. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study. Stroke 1992, 23:1062-1068.
15. Teynor A., Caviezel S., Dratva J., Kunzli N., Schmidt-Trucksass A. An automated, interactive analysis system for ultrasound sequences of the common carotid artery. Ultrasound Med. Biol. 2012, 38:1440-1450.
16. Sillesen H. Carotid intima-media thickness and/or carotid plaque: what is relevant?. Eur. J. Vasc. Endovasc. Surg. 2014, 48:115-117.
17. Molinari F., Meiburger K.M., Saba L., et al. Ultrasound IMT measurement on a multi-ethnic and multi-institutional database: our review and experience using four fully automated and one semi-automated methods. Comput Methods Programs Biomed. 2012, 108:946-960.
18. Rossi A.C., Brands P.J., Hoeks A.P. Automatic localization of intimal and adventitial carotid artery layers with noninvasive ultrasound: a novel algorithm providing scan quality control. Ultrasound Med. Biol. 2010, 36:467-479.
19. Selzer R.H., Mack W.J., Lee P.L., Kwong-Fu H., Hodis H.N. Improved common carotid elasticity and intima-media thickness measurements from computer analysis of sequential ultrasound frames. Atherosclerosis 2001, 154:185-193.
20. Hoeks A.P., Willekes C., Boutouyrie P., Brands P.J., Willigers J.M., Reneman R.S. Automated detection of local artery wall thickness based on M-line signal processing. Ultrasound Med. Biol. 1997, 23:1017-1023.
21. Schreuder F.H., Graf M., Hameleers J.M., Mess W.H., Hoeks A.P. Measurement of common carotid artery intima-media thickness in clinical practice: comparison of B-mode and RF-based technique. Ultraschall Med. 2009, 30:459-465.
22. Bianchini E., Bozec E., Gemignani V., et al. Assessment of carotid stiffness and intima-media thickness from ultrasound data: comparison between two methods. J.Ultrasound Med. 2010, 29:1169-1175.
23. Mancia G., Fagard R., et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 2013, 34:2159-2219. Authors/Task Force M.
24. Perk J., De Backer G., Gohlke H., et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 2012, 33:1635-1701.
25. Homma S., Hirose N., Ishida H., Ishii T., Araki G. Carotid plaque and intima-media thickness assessed by b-mode ultrasonography in subjects ranging from young adults to centenarians. Stroke 2001, 32:830-835.
26. Sakakura K., Nakano M., Otsuka F., Ladich E., Kolodgie F.D., Virmani R. Pathophysiology of atherosclerosis plaque progression. Heart Lung Circ. 2013, 22:399-411.
27. Inaba Y., Chen J.A., Bergmann S.R. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis 2012, 220:128-133.
28. Makris G.C., Lavida A., Griffin M., Geroulakos G., Nicolaides A.N. Three-dimensional ultrasound imaging for the evaluation of carotid atherosclerosis. Atherosclerosis 2011, 219:377-383.
29. Staub D., Partovi S., Schinkel A.F., et al. Correlation of carotid artery atherosclerotic lesion echogenicity and severity at standard US with intraplaque neovascularization detected at contrast-enhanced US. Radiology 2011, 258:618-626.
30. Landry A., Spence J.D., Fenster A. Quantification of carotid plaque volume measurements using 3D ultrasound imaging. Ultrasound Med. Biol. 2005, 31:751-762.
31. Polak J.F., Szklo M., Kronmal R.A., et al. The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis. J.Am. Heart Assoc. 2013, 2:e000087.
32. Lorenz M.W., Polak J.F., Kavousi M., et al. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet 2012, 379:2053-2062.
33. Den Ruijter H.M., Peters S.A., Anderson T.J., et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA 2012, 308:796-803.
34. den Ruijter H.M., Peters S.A., Groenewegen K.A., et al. Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative. Diabetologia 2013, 56:1494-1502.
35. Peters S.A., den Ruijter H.M., Bots M.L., Moons K.G. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart 2012, 98:177-184.
36. Sehestedt T., Jeppesen J., Hansen T.W., et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur. Heart J. 2010, 31:883-891.
37. Plichart M., Celermajer D.S., Zureik M., et al. Carotid intima-media thickness in plaque-free site, carotid plaques and coronary heart disease risk prediction in older adults. The Three-City Study. Atherosclerosis 2011, 219:917-924.
38. Nambi V., Chambless L., Folsom A.R., et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk in Communities) study. J.Am. Coll. Cardiol. 2010, 55:1600-1607.
39. Polak J.F., Pencina M.J., Pencina K.M., O'Donnell C.J., Wolf P.A., D'Agostino R.B. Carotid-wall intima-media thickness and cardiovascular events. N.Engl. J. Med. 2011, 365:213-221.
40. Xie W., Wu Y., Wang W., et al. Alongitudinal study of carotid plaque and risk of ischemic cardiovascular disease in the Chinese population. J.Am. Soc. Echocardiogr. 2011, 24:729-737.
41. Korcarz C.E., DeCara J.M., Hirsch A.T., et al. Ultrasound detection of increased carotid intima-media thickness and carotid plaque in an office practice setting: does it affect physician behavior or patient motivation?. J.Am. Soc. Echocardiogr.: Off. Publ. Am. Soc. Echocardiogr. 2008, 21:1156-1162.
42. Johnson H.M., Turke T.L., Grossklaus M., et al. Effects of an office-based carotid ultrasound screening intervention. J.Am. Soc. Echocardiogr. 2011, 24:738-747.
43. Rodondi N., Collet T.H., Nanchen D., et al. Impact of carotid plaque screening on smoking cessation and other cardiovascular risk factors: a randomized controlled trial. Arch. Intern Med. 2012, 172:344-352.
44. Makris G.C., Lavida A., Nicolaides A.N., Geroulakos G. The effect of statins on carotid plaque morphology: a LDL-associated action or one more pleiotropic effect of statins?. Atherosclerosis 2010, 213:8-20.
45. Bots M.L., Visseren F.L., Evans G.W., et al. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. Lancet 2007, 370:153-160.
46. den Ruijter H.M., Vaartjes I., Sutton-Tyrrell K., Bots M.L., Koffijberg H. Long-term health benefits and costs of measurement of carotid intima-media thickness in prevention of coronary heart disease. J.Hypertens. 2013, 31:782-790.
47. Engelen L., Ferreira I., Stehouwer C.D., Boutouyrie P., Laurent S. Reference values for arterial measurements C. Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors. Eur. Heart J. 2013, 34:2368-2380.
48. Sillesen H., Muntendam P., Adourian A., et al. Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage Study. JACC Cardiovasc Imaging 2012, 5:681-689.
49. L. Fernandez-Friera, J.L. Penalvo, A. Fernandez-Ortiz, et al., Prevalence, vascular distribution and multi-territorial extent of subclinical atherosclerosis in a middle-aged cohort: the PESA (Progression of early subclinical atherosclerosis) study, Circulation. Published online before print April 16, 2015,. http://dx.doi.org/10.1161/CIRCULATIONAHA.114.014310.
50. Baber U., Mehran R., Sartori S., et al. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. J.Am. Coll. Cardiol. 2015, 65:1065-1074.
51. Aldridge M.E., Do K., Oo T., Naqvi T.Z. Carotid intima-media thickness and plaque assessment by trained medical residents: validation and preliminary testing of a training protocol. J.Am. Soc. Echocardiogr. 2013, 26:1457-1464.
52. Greenland P., Alpert J.S., Beller G.A., et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010, 122:e584-636.
53. Yao S.T., Hobbs J.T., Irvine W.T. Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br. J. Surg. 1969, 56:676-679.
54. Criqui M.H., Langer R.D., Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N.Engl. J. Med. 1992, 326:381-386.
55. Aboyans V., Criqui M.H., Abraham P., et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 2012, 126:2890-2909.
56. Aboyans V., Criqui M.H., McClelland R.L., et al. Intrinsic contribution of gender and ethnicity to normal ankle-brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA). J.Vasc. Surg. 2007, 45:319-327.
57. Fowkes F.G., Murray G.D., Butcher I., et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008, 300:197-208.
58. Aboyans V., Ho E., Denenberg J.O., Ho L.A., Natarajan L., Criqui M.H. The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J.Vasc. Surg. 2008, 48:1197-1203.
59. Aboyans V., Lacroix P., Tran M.H., et al. The prognosis of diabetic patients with high ankle-brachial index depends on the coexistence of occlusive peripheral artery disease. J.Vasc. Surg. 2011, 53:984-991.
60. Suominen V., Uurto I., Saarinen J., Venermo M., Salenius J. PAD as a risk factor for mortality among patients with elevated ABI-a clinical study. Eur. J. Vasc. Endovasc. Surg. 2010, 39:316-322.
61. Murphy T.P., Dhangana R., Pencina M.J., D'Agostino R.B. Ankle-brachial index and cardiovascular risk prediction: an analysis of 11,594 individuals with 10-year follow-up. Atherosclerosis 2012, 220:160-167.
62. Verberk W.J., Kollias A., Stergiou G.S. Automated oscillometric determination of the ankle-brachial index: a systematic review and meta-analysis. Hypertens. Res. 2012, 35:883-891.
63. Fowkes F., Murray G., Butcher I., et al. Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events. Eur. J. Prev. Cardiol. 2014, 21:310-320.
64. Yeboah J., McClelland R.L., Polonsky T.S., et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 2012, 308:788-795.
65. Fowkes F.G., Price J.F., Stewart M.C., et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA 2010, 303:841-848.
66. Belch J., MacCuish A., Campbell I., et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008, 337:a1840.
67. Pande R.L., Perlstein T.S., Beckman J.A., Creager M.A. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation 2011, 124:17-23.
68. Gasecki D., Rojek A., Kwarciany M., et al. Pulse wave velocity is associated with early clinical outcome after ischemic stroke. Atherosclerosis 2012, 225:348-352.
69. Criqui M.H., Ninomiya J.K., Wingard D.L., Ji M., Fronek A. Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J.Am. Coll. Cardiol. 2008, 52:1736-1742.
70. Ryden L., Grant P.J., et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur. Heart J. 2013, 34:3035-3087. Authors/Task Force M.
71. Moyer V.A. Force USPST. Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement. Ann. Intern Med. 2013, 159:342-348.
72. van Sloten T.T., Schram M.T., van den Hurk K., et al. Local stiffness of the carotid and femoral artery is associated with incident cardiovascular events and all-cause mortality - the Hoorn Study. J.Am. Coll. Cardiol. 2014, 63:1739-1747.
73. Shirai K., Hiruta N., Song M., et al. Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J.Atheroscler. Thromb. 2011, 18:924-938.
74. Laurent S., Cockcroft J., Van Bortel L., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J. 2006, 27:2588-2605.
75. Asmar R., Benetos A., Topouchian J., et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995, 26:485-490.
76. Van Bortel L.M., Laurent S., Boutouyrie P., et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J.Hypertens. 2012, 30:445-448.
77. Cruickshank K., Riste L., Anderson S.G., Wright J.S., Dunn G., Gosling R.G. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation 2002, 106:2085-2090.
78. London G.M., Blacher J., Pannier B., Guerin A.P., Marchais S.J., Safar M.E. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001, 38:434-438.
79. Zanoli L., Cannavo M., Rastelli S., et al. Arterial stiffness is increased in patients with inflammatory bowel disease. J.Hypertens. 2012, 30:1775-1781.
80. Boutouyrie P., Tropeano A.I., Asmar R., et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002, 39:10-15.
81. Laurent S., Boutouyrie P., Asmar R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001, 37:1236-1241.
82. Laurent S., Katsahian S., Fassot C., et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003, 34:1203-1206.
83. Blacher J., Guerin A.P., Pannier B., Marchais S.J., Safar M.E., London G.M. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999, 99:2434-2439.
84. Meaume S., Benetos A., Henry O.F., Rudnichi A., Safar M.E. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler. Thromb. Vasc. Biol. 2001, 21:2046-2050.
85. Sutton-Tyrrell K., Najjar S.S., Boudreau R.M., et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005, 111:3384-3390.
86. Mattace-Raso F.U., van der Cammen T.J., Hofman A., et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006, 113:657-663.
87. Gasecki D., Rojek A., Kwarciany M., et al. Aortic stiffness predicts functional outcome in patients after ischemic stroke. Stroke 2012, 43:543-544.
88. Ben-Shlomo Y., Spears M., Boustred C., et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J.Am. Coll. Cardiol. 2014, 63:636-646.
89. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J.Am. Coll. Cardiol. 2010, 55:1318-1327.
90. Laurent S., Briet M., Boutouyrie P. Arterial stiffness as surrogate end point: needed clinical trials. Hypertension 2012, 60:518-522.
91. Sehestedt T., Jeppesen J., Hansen T.W., et al. Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population. J.Hypertens. 2009, 27:2351-2357.
92. Mitchell G.F., Hwang S.J., Vasan R.S., et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010, 121:505-511.
93. Karras A., Haymann J.P., Bozec E., et al. Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension 2012, 60:1451-1457.
94. Guerin A.P., Blacher J., Pannier B., Marchais S.J., Safar M.E., London G.M. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001, 103:987-992.
95. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur. Heart J. 2010, 31:2338-2350.
96. Vermeersch S.J., Rietzschel E.R., De Buyzere M.L., et al. Distance measurements for the assessment of carotid to femoral pulse wave velocity. J.Hypertens. 2009, 27:2377-2385.
97. Cecelja M., Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 2009, 54:1328-1336.
98. Yamashina A., Tomiyama H., Takeda K., et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens. Res. 2002, 25:359-364.
99. Tomiyama H., Hashimoto H., Hirayama Y., et al. Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose. Hypertension 2006, 47:180-188.
100. Ninomiya T., Kojima I., Doi Y., et al. Brachial-ankle pulse wave velocity predicts the development of cardiovascular disease in a general Japanese population: the Hisayama Study. J.Hypertens. 2013, 31:477-483. Discussion 83.
101. Tomiyama H., Koji Y., Yambe M., et al. Brachial - ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ. J. 2005, 69:815-822.
102. Yamashina A., Tomiyama H., Arai T., et al. Nomogram of the relation of brachial-ankle pulse wave velocity with blood pressure. Hypertens. Res. 2003, 26:801-806.
103. Tomiyama H., Yamashina A. Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ. J. 2010, 74:24-33.
104. Yamashina A., Tomiyama H., Arai T., et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens. Res. 2003, 26:615-622.
105. Kitahara T., Ono K., Tsuchida A., et al. Impact of brachial-ankle pulse wave velocity and ankle-brachial blood pressure index on mortality in hemodialysis patients. Am. J. Kidney Dis. 2005, 46:688-696.
106. Meguro T., Nagatomo Y., Nagae A., et al. Elevated arterial stiffness evaluated by brachial-ankle pulse wave velocity is deleterious for the prognosis of patients with heart failure. Circ. J. 2009, 73:673-680.
107. Vlachopoulos C., Aznaouridis K., Terentes-Printzios D., Ioakeimidis N., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis. Hypertension 2012, 60:556-562.
108. Toyama K., Sugiyama S., Oka H., et al. Combination treatment of rosuvastatin or atorvastatin, with regular exercise improves arterial wall stiffness in patients with coronary artery disease. PLoS One 2012, 7:e41369.
109. Ai Z.S., Li J., Liu Z.M., et al. Reference value of brachial-ankle pulse wave velocity for the eastern Chinese population and potential influencing factors. Braz J. Med. Biol. Res. 2011, 44:1000-1005.
110. Wang X., Xie J., Zhang L.J., Hu D.Y., Luo Y.L., Wang J.W. Reference values of brachial-ankle pulse wave velocity for Northern Chinese. Chin. Med. J. Engl. 2009, 122:2103-2106.
111. Nichols W.W., ÓRourke M.F., Vlachopoulos C. McDonald's Blood Flow in Arteries 2011, Hodder Arnold, London.
112. Avolio A.P., Van Bortel L.M., Boutouyrie P., et al. Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension 2009, 54:375-383.
113. Namasivayam M., McDonnell B.J., McEniery C.M., O'Rourke M.F. Anglo-Cardiff Collaborative Trial Study I. Does wave reflection dominate age-related change in aortic blood pressure across the human life span?. Hypertension 2009, 53:979-985.
114. Kips J.G., Rietzschel E.R., De Buyzere M.L., et al. Evaluation of noninvasive methods to assess wave reflection and pulse transit time from the pressure waveform alone. Hypertension 2009, 53:142-149.
115. Verbeke F., Marechal C., Van Laecke S., et al. Aortic stiffness and central wave reflections predict outcome in renal transplant recipients. Hypertension 2011, 58:833-838.
116. Chirinos J.A., Kips J.G., Jacobs D.R., et al. Arterial wave reflections and incident cardiovascular events and heart failure: MESA (Multiethnic Study of Atherosclerosis). J.Am. Coll. Cardiol. 2012, 60:2170-2177.
117. Kingwell B.A., Waddell T.K., Medley T.L., Cameron J.D., Dart A.M. Large artery stiffness predicts ischemic threshold in patients with coronary artery disease. J.Am. Coll. Cardiol. 2002, 40:773-779.
118. Nichols W.W., Denardo S.J., Johnson B.D., Sharaf B.L., Bairey Merz C.N., Pepine C.J. Increased wave reflection and ejection duration in women with chest pain and nonobstructive coronary artery disease: ancillary study from the Women's ischemia Syndrome Evaluation. J.Hypertens. 2013, 31:1447-1454. Discussion 54-5.
119. Hashimoto J., Nichols W.W., O'Rourke M.F., Imai Y. Association between wasted pressure effort and left ventricular hypertrophy in hypertension: influence of arterial wave reflection. Am. J. Hypertens. 2008, 21:329-333.
120. Hashimoto J., Imai Y., O'Rourke M.F. Indices of pulse wave analysis are better predictors of left ventricular mass reduction than cuff pressure. Am. J. Hypertens. 2007, 20:378-384.
121. Weber T., Wassertheurer S., O'Rourke M.F., et al. Pulsatile hemodynamics in patients with exertional dyspnea: potentially of value in the diagnostic evaluation of suspected heart failure with preserved ejection fraction. J.Am. Coll. Cardiol. 2013, 61:1874-1883.
122. Holland D.J., Sacre J.W., Leano R.L., Marwick T.H., Sharman J.E. Contribution of abnormal central blood pressure to left ventricular filling pressure during exercise in patients with heart failure and preserved ejection fraction. J.Hypertens. 2011, 29:1422-1430.
123. Verbeke F., Van Biesen W., Peeters P., Van Bortel L.M., Vanholder R.C. Arterial stiffness and wave reflections in renal transplant recipients. Nephrol. Dial. Transpl. 2007, 22:3021-3027.
124. Weber T., Ammer M., Gunduz D., Bruckenberger P., Eber B., Wallner M. Association of increased arterial wave reflections with decline in renal function in chronic kidney disease stages 3 and 4. Am. J. Hypertens. 2011, 24:762-769.
125. Weber T., Auer J., O'Rourke M.F., et al. Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur. Heart J. 2005, 26:2657-2663.
126. Chirinos J.A., Zambrano J.P., Chakko S., et al. Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 2005, 45:980-985.
127. Sung S.H., Yu W.C., Cheng H.M., et al. Excessive wave reflections on admission predict post-discharge events in patients hospitalized due to acute heart failure. Eur. J. Heart Fail 2012, 14:1348-1355.
128. Wang K.L., Cheng H.M., Sung S.H., et al. Wave reflection and arterial stiffness in the prediction of 15-year all-cause and cardiovascular mortalities: a community-based study. Hypertension 2010, 55:799-805.
129. Williams B., Lacy P.S., Thom S.M., et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006, 113:1213-1225.
130. Benetos A., Gautier S., Labat C., et al. Mortality and cardiovascular events are best predicted by low central/peripheral pulse pressure amplification but not by high blood pressure levels in elderly nursing home subjects: the PARTAGE (Predictive Values of Blood Pressure and Arterial Stiffness in institutionalized Very Aged Population) study. J.Am. Coll. Cardiol. 2012, 60:1503-1511.
131. Vlachopoulos C., Aznaouridis K., O'Rourke M.F., Safar M.E., Baou K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur. Heart J. 2010, 31:1865-1871.
132. "Central Pulse Pressure versus Peripheral Pulse Pressure": Case Still Open? 2010, Eur Heart J web site, accessed 26.08.14, at. http://eurheartj.oxfordjournals.org/content/early/2010/03/02/eurheartj.ehq024/reply-ehj_el_240.
133. Central pulse pressure versus peripheral pulse pressure: case still open?. Oxf. J. 2010, Towards the final verdict. Re:, accessed 26.08.14, at. http://eurheartj.oxfordjournals.org/content/early/2010/03/02/eurheartj.ehq024/reply-ehj_el_240.
134. de Luca N., Asmar R.G., London G.M., O'Rourke M.F., Safar M.E., Investigators R.P. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J.Hypertens. 2004, 22:1623-1630.
135. Hashimoto J., Westerhof B.E., Westerhof N., Imai Y., O'Rourke M.F. Different role of wave reflection magnitude and timing on left ventricular mass reduction during antihypertensive treatment. J.Hypertens. 2008, 26:1017-1024.
136. Sharman J.E., Marwick T.H., Gilroy D., et al. Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care: principal findings of the BP GUIDE study. Hypertension 2013, 62:1138-1145.
137. O'Rourke M.F., Vlachopoulos C., Graham R.M. Spurious systolic hypertension in youth. Vasc. Med. 2000, 5:141-145.
138. Protogerou A.D., Argyris A.A., Papaioannou T.G., et al. Left-ventricular hypertrophy is associated better with 24-h aortic pressure than 24-h brachial pressure in hypertensive patients: the SAFAR study. J.Hypertens. 2014, 32:1805-1814.
139. Weber T., Wassertheurer S., Rammer M., et al. Validation of a brachial cuff-based method for estimating central systolic blood pressure. Hypertension 2011, 58:825-832.
140. Pucci G., Cheriyan J., Hubsch A., et al. Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure. J.Hypertens. 2013, 31:77-85.
141. Agabiti-Rosei E., Mancia G., O'Rourke M.F., et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 2007, 50:154-160.
142. Herbert A., Cruickshank J.K., Laurent S., Boutouyrie P. Reference values for arterial measurements C. Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors. Eur. Heart J. 2014, 35:3122-3133.
143. Lekakis J., Abraham P., Balbarini A., et al. Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. Eur. J. Cardiovasc Prev. Rehabil. 2011, 18:775-789.
144. Balletshofer B.M., Rittig K., Stock J., et al. Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness. Atherosclerosis 2003, 171:303-309.
145. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992, 340:1111-1115.
146. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J.Am. Coll. Cardiol. 2002, 39:257-265.
147. Doshi S.N., Naka K.K., Payne N., et al. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin. Sci. (Lond.) 2001, 101:629-635.
148. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J.Am. Coll. Cardiol. 1995, 26:1235-1241.
149. Wang T.J. Multiple biomarkers for predicting cardiovascular events: lessons learned. J.Am. Coll. Cardiol. 2010, 55:2092-2095.
150. Bechlioulis A., Kalantaridou S.N., Naka K.K., et al. Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J.Clin. Endocrinol. Metab. 2010, 95:1199-1206.
151. Inaba Y., Chen J.A., Bergmann S.R. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int. J. Cardiovasc Imaging 2010, 26:631-640.
152. Ras R.T., Streppel M.T., Draijer R., Zock P.L. Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int. J. Cardiol. 2013, 168:344-351.
153. Xu Y., Arora R.C., Hiebert B.M., et al. Non-invasive endothelial function testing and the risk of adverse outcomes: a systematic review and meta-analysis. Eur. Heart J. Cardiovasc Imaging 2014, 15:736-746.
154. Peters S.A., den Ruijter H.M., Bots M.L. The incremental value of brachial flow-mediated dilation measurements in risk stratification for incident cardiovascular events: a systematic review. Ann. Med. 2012, 44:305-312.
155. Lind L., Berglund L., Larsson A., Sundstrom J. Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation 2011, 123:1545-1551.
156. Charakida M., Masi S., Luscher T.F., Kastelein J.J., Deanfield J.E. Assessment of atherosclerosis: the role of flow-mediated dilatation. Eur. Heart J. 2010, 31:2854-2861.
157. Briet M., Collin C., Laurent S., et al. Endothelial function and chronic exposure to air pollution in normal male subjects. Hypertension 2007, 50:970-976.
158. Modena M.G., Bonetti L., Coppi F., Bursi F., Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J.Am. Coll. Cardiol. 2002, 40:505-510.
159. Landmesser U., von Eckardstein A., Kastelein J., Deanfield J., Luscher T.F. Increasing high-density lipoprotein cholesterol by cholesteryl ester transfer protein-inhibition: a rocky road and lessons learned? The early demise of the dal-HEART programme. Eur. Heart J. 2012, 33:1712-1715.
160. Kitta Y., Obata J.E., Nakamura T., et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J.Am. Coll. Cardiol. 2009, 53:323-330.
161. Ghiadoni L., Faita F., Salvetti M., et al. Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study. J.Hypertens. 2012, 30:1399-1405.
162. Schier R., Marcus H.E., Mansur E., et al. Evaluation of digital thermal monitoring as a tool to assess perioperative vascular reactivity. J.Atheroscler. Thromb. 2013, 20:277-286.
163. Ahmadi N., Nabavi V., Nuguri V., et al. Low fingertip temperature rebound measured by digital thermal monitoring strongly correlates with the presence and extent of coronary artery disease diagnosed by 64-slice multi-detector computed tomography. Int. J. Cardiovasc Imaging 2009, 25:725-738.
164. Millasseau S.C., Ritter J.M., Takazawa K., Chowienczyk P.J. Contour analysis of the photoplethysmographic pulse measured at the finger. J.Hypertens. 2006, 24:1449-1456.
165. Gordon S.E., Cartwright N., Griffiths M.J. Investigation of endothelial function by pulse contour analysis: a protocol for drug administration and timing of pulse contour assessment. Br. J. Clin. Pharmacol. 2009, 68:630-633.
166. Hamburg N.M., Palmisano J., Larson M.G., et al. Relation of brachial and digital measures of vascular function in the community: the Framingham heart study. Hypertension 2011, 57:390-396.
167. Schnabel R.B., Schulz A., Wild P.S., et al. Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods. Circ. Cardiovasc Imaging 2011, 4:371-380.
168. Kuvin J.T., Patel A.R., Sliney K.A., et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am. Heart J. 2003, 146:168-174.
169. Flammer A.J., Anderson T., Celermajer D.S., et al. The assessment of endothelial function: from research into clinical practice. Circulation 2012, 126:753-767.
170. Hamburg N.M., Keyes M.J., Larson M.G., et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008, 117:2467-2474.
171. Mulukutla S.R., Venkitachalam L., Bambs C., et al. Black race is associated with digital artery endothelial dysfunction: results from the Heart SCORE study. Eur. Heart J. 2010, 31:2808-2815.
172. Heffernan K.S., Karas R.H., Patvardhan E.A., Jafri H., Kuvin J.T. Peripheral arterial tonometry for risk stratification in men with coronary artery disease. Clin. Cardiol. 2010, 33:94-98.
173. Toggweiler S., Schoenenberger A., Urbanek N., Erne P. The prevalence of endothelial dysfunction in patients with and without coronary artery disease. Clin. Cardiol. 2010, 33:746-752.
174. Matsuzawa Y., Sugiyama S., Sugamura K., et al. Digital assessment of endothelial function and ischemic heart disease in women. J.Am. Coll. Cardiol. 2010, 55:1688-1696.
175. Matsue Y., Suzuki M., Nagahori W., et al. Endothelial dysfunction measured by peripheral arterial tonometry predicts prognosis in patients with heart failure with preserved ejection fraction. Int. J. Cardiol. 2013, 168:36-40.
176. Akiyama E., Sugiyama S., Matsuzawa Y., et al. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. J.Am. Coll. Cardiol. 2012, 60:1778-1786.
177. Rubinshtein R., Kuvin J.T., Soffler M., et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur. Heart J. 2010, 31:1142-1148.
178. Hamilos M., Muller O., Ntalianis A., et al. Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel. J.Thromb. Thrombolysis 2011, 32:64-71.
179. Koska J., Schwartz E.A., Mullin M.P., Schwenke D.C., Reaven P.D. Improvement of postprandial endothelial function after a single dose of exenatide in individuals with impaired glucose tolerance and recent-onset type 2 diabetes. Diabetes Care 2010, 33:1028-1030.
180. Aversa A., Vitale C., Volterrani M., et al. Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes. Diabet. Med. 2008, 25:37-44.
181. Kim J.Y., Paik J.K., Kim O.Y., et al. Effects of lycopene supplementation on oxidative stress and markers of endothelial function in healthy men. Atherosclerosis 2011, 215:189-195.
182. Widmer R.J., Freund M.A., Flammer A.J., et al. Beneficial effects of polyphenol-rich olive oil in patients with early atherosclerosis. Eur. J. Nutr. 2013, 52:1223-1231.
183. Fraley A.E., Tsimikas S. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. Curr. Opin. Lipidol. 2006, 17:502-509.
184. Tsimikas S., Brilakis E.S., Miller E.R., et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N.Engl. J. Med. 2005, 353:46-57.
185. Holvoet P., Jenny N.S., Schreiner P.J., Tracy R.P., Jacobs D.R. Multi-Ethnic Study of A. The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007, 194:245-252.
186. Landmesser U. High density lipoprotein - should we raise it?. Curr. Vasc. Pharmacol. 2012, 10:718-719.
187. Otocka-Kmiecik A., Mikhailidis D.P., Nicholls S.J., Davidson M., Rysz J., Banach M. Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?. Prog. Lipid Res. 2012, 51:314-324.
188. Silbernagel G., Schottker B., Appelbaum S., et al. High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality. Eur. Heart J. 2013, 34:3563-3571.
189. Yousuf O., Mohanty B.D., Martin S.S., et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?. J.Am. Coll. Cardiol. 2013, 62:397-408.
190. Inoue T., Kato T., Uchida T., et al. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. J.Am. Coll. Cardiol. 2005, 46:239-245.
191. Emerging Risk Factors C, Kaptoge S., Di Angelantonio E., et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375:132-140.
192. Emerging Risk Factors C, Kaptoge S., Di Angelantonio E., et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N.Engl. J. Med. 2012, 367:1310-1320.
193. Paffen E., DeMaat M.P. C-reactive protein in atherosclerosis: a causal factor?. Cardiovasc Res. 2006, 71:30-39.
194. Ridker P.M., Danielson E., Fonseca F.A., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N.Engl. J. Med. 2008, 359:2195-2207.
195. European Association for Cardiovascular P, Rehabilitation, Reiner Z., et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur. Heart J. 2011, 32:1769-1818.
196. Stone N.J., Robinson J., Lichtenstein A.H., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the american college of Cardiology/American heart association task force on practice guidelines. J.Am. Coll. Cardiol. 2014, 63(25 Pt B):2889-2934.
197. Safar M.E., Rizzoni D., Blacher J., Muiesan M.L., Agabiti-Rosei E. Macro and microvasculature in hypertension: therapeutic aspects. J.Hum. Hypertens. 2008, 22:590-595.
198. Westerhof B.E., van den Wijngaard J.P., Murgo J.P., Westerhof N. Location of a reflection site is elusive: consequences for the calculation of aortic pulse wave velocity. Hypertension 2008, 52:478-483.
199. Muiesan M.L., Salvetti M., Rizzoni D., et al. Pulsatile hemodynamics and microcirculation: evidence for a close relationship in hypertensive patients. Hypertension 2013, 61:130-136.
200. Boari G.E., Rizzardi N., de Ciuceis C., et al. Determinants of the structure of resistance-sized arteries in hypertensive patients. Blood Press 2008, 17:204-211.
201. Rizzoni D., Porteri E., Boari G.E., et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003, 108:2230-2235.
202. Hashimoto J., Aikawa T., Imai Y. Large artery stiffening as a link between cerebral lacunar infarction and renal albuminuria. Am. J. Hypertens. 2008, 21:1304-1309.
203. Brisset M., Boutouyrie P., Pico F., et al. Large-vessel correlates of cerebral small-vessel disease. Neurology 2013, 80:662-669.
204. Ott C., Raff U., Harazny J.M., Michelson G., Schmieder R.E. Central pulse pressure is an independent determinant of vascular remodeling in the retinal circulation. Hypertension 2013, 61:1340-1345.
205. Laurent S., Briet M., Boutouyrie P. Large and small artery cross-talk and recent morbidity-mortality trials in hypertension. Hypertension 2009, 54:388-392.
206. Park J.B., Schiffrin E.L. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J.Hypertens. 2001, 19:921-930.
207. Agabiti-Rosei E., Heagerty A.M., Rizzoni D. Effects of antihypertensive treatment on small artery remodelling. J.Hypertens. 2009, 27:1107-1114.
208. Rossi R., Chiurlia E., Nuzzo A., Cioni E., Origliani G., Modena M.G. Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. J.Am. Coll. Cardiol. 2004, 44:1636-1640.
209. Kaess B.M., Rong J., Larson M.G., et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 2012, 308:875-881.
210. Shimbo D., Muntner P., Mann D., et al. Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis. Hypertension 2010, 55:1210-1216.
211. Liao D., Arnett D.K., Tyroler H.A., et al. Arterial stiffness and the development of hypertension. The ARIC study. Hypertension 1999, 34:201-206.
212. Dernellis J., Panaretou M. Aortic stiffness is an independent predictor of progression to hypertension in nonhypertensive subjects. Hypertension 2005, 45:426-431.
213. Takase H., Dohi Y., Toriyama T., et al. Brachial-ankle pulse wave velocity predicts increase in blood pressure and onset of hypertension. Am. J. Hypertens. 2011, 24:667-673.
214. Tomiyama H., O'Rourke M.F., Hashimoto H., et al. Central blood pressure: a powerful predictor of the development of hypertension. Hypertens. Res. 2013, 36:19-24.
215. Peralta C.A., Adeney K.L., Shlipak M.G., et al. Structural and functional vascular alterations and incident hypertension in normotensive adults: the Multi-Ethnic Study of Atherosclerosis. Am. J. Epidemiol. 2010, 171:63-71.
216. Tomiyama H., Matsumoto C., Yamada J., et al. Predictors of progression from prehypertension to hypertension in Japanese men. Am. J. Hypertens. 2009, 22:630-636.
217. Najjar S.S., Scuteri A., Shetty V., et al. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J.Am. Coll. Cardiol. 2008, 51:1377-1383.
218. Terai M., Ohishi M., Ito N., et al. Comparison of arterial functional evaluations as a predictor of cardiovascular events in hypertensive patients: the Non-Invasive Atherosclerotic Evaluation in Hypertension (NOAH) study. Hypertens. Res. 2008, 31:1135-1145.
219. Munakata M., Konno S., Miura Y., Yoshinaga K., Group J.T.S. Prognostic significance of the brachial-ankle pulse wave velocity in patients with essential hypertension: final results of the J-TOPP study. Hypertens. Res. 2012, 35:839-842.
220. Protogerou A.D., Stergiou G.S., Vlachopoulos C., Blacher J., Achimastos A. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: evidence for specific class-effects of antihypertensive drugs on pressure amplification. Curr. Pharm. Des. 2009, 15:272-289.
221. Davies J.E., Lacy P., Tillin T., et al. Excess pressure integral predicts cardiovascular events independent of other risk factors in the conduit artery functional evaluation substudy of Anglo-Scandinavian Cardiac Outcomes Trial. Hypertension 2014, 64:60-68.
222. Bots M.L., Groenewegen K.A., Anderson T.J., et al. Common carotid intima-media thickness measurements do not improve cardiovascular risk prediction in individuals with elevated blood pressure: the USE-IMT collaboration. Hypertension 2014, 63:1173-1181.
223. Zanchetti A., Hennig M., Hollweck R., et al. Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA). Circulation 2009, 120:1084-1090.
224. Muris D.M., Houben A.J., Schram M.T., Stehouwer C.D. Microvascular dysfunction is associated with a higher incidence of type 2 diabetes mellitus: a systematic review and meta-analysis. Arterioscler. Thromb. Vasc. Biol. 2012, 32:3082-3094.
225. Izzo R., de Simone G., Trimarco V., et al. Hypertensive target organ damage predicts incident diabetes mellitus. Eur. Heart J. 2013, 34:3419-3426.
226. Hanssen N.M., Huijberts M.S., Schalkwijk C.G., Nijpels G., Dekker J.M., Stehouwer C.D. Associations between the ankle-brachial index and cardiovascular and all-cause mortality are similar in individuals without and with type 2 diabetes: nineteen-year follow-up of a population-based cohort study. Diabetes Care 2012, 35:1731-1735.
227. Kavousi M., Elias-Smale S., Rutten J.H., et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann. Intern Med. 2012, 156:438-444.
228. Nordestgaard B.G., Chapman M.J., Humphries S.E., et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur. Heart J. 2013, 34:3478-3490a.
229. Selvin E., Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004, 110:738-743.
230. Brevetti G., Schiano V., Verdoliva S., et al. Peripheral arterial disease and cardiovascular risk in Italy. Results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study. J.Cardiovasc Med. Hagerst. 2006, 7:608-613.
231. Diehm C., Allenberg J.R., Pittrow D., et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009, 120:2053-2061.
232. Steg P.G., Bhatt D.L., Wilson P.W., et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007, 297:1197-1206.
233. Gallino A., Aboyans V., Diehm C., et al. Non-coronary atherosclerosis. Eur. Heart J. 2014, 35:1112-1119.
234. van Holten T.C., Waanders L.F., de Groot P.G., et al. Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses. PLoS One 2013, 8:e62080.
235. Hafner F., Seinost G., Gary T., Froehlich H., Pilger E., Brodmann M. Are flow-mediated vasodilatation and intima-media thickness of the brachial artery associated with restenosis after endovascular treatment of peripheral arterial occlusive disease?. Eur. Radiol. 2010, 20:2533-2540.
236. Urbonaviciene G., Frystyk J., Flyvbjerg A., Urbonavicius S., Henneberg E.W., Lindholt J.S. Markers of inflammation in relation to long-term cardiovascular mortality in patients with lower-extremity peripheral arterial disease. Int. J. Cardiol. 2012, 160:89-94.
237. Dorresteijn J.A., Visseren F.L., Wassink A.M., et al. Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score. Heart 2013, 99:866-872.
238. Santos-Garcia D., Blanco M., Serena J., Rodriguez-Yanez M., Leira R., Castillo J. Impaired brachial flow-mediated dilation is a predictor of a new-onset vascular event after stroke. Cerebrovasc. Dis. 2011, 32:155-162.
239. Tsivgoulis G., Vemmos K., Papamichael C., et al. Common carotid artery intima-media thickness and the risk of stroke recurrence. Stroke 2006, 37:1913-1916.
240. Folsom A.R. Classical and novel biomarkers for cardiovascular risk prediction in the United States. J.Epidemiol. 2013, 23:158-162.
241. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N.Engl. J. Med. 2004, 351:1296-1305.
242. Pasqualini L., Schillaci G., Pirro M., et al. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease. J.Intern Med. 2007, 262:668-677.
243. Luscher T.F., Taddei S., Kaski J.C., et al. Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial. Eur. Heart J. 2012, 33:857-865.
244. Fayad Z.A., Mani V., Woodward M., et al. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet 2011, 378:1547-1559.
245. Schwartz G.G., Olsson A.G., Abt M., et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N.Engl. J. Med. 2012, 367:2089-2099.
246. Kastelein J.J., van Leuven S.I., Burgess L., et al. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N.Engl. J. Med. 2007, 356:1620-1630.
247. Barter P.J., Caulfield M., Eriksson M., et al. Effects of torcetrapib in patients at high risk for coronary events. N.Engl. J. Med. 2007, 357:2109-2122.
248. Muiesan M.L., Salvetti M., Monteduro C., et al. Effect of treatment on flow-dependent vasodilation of the brachial artery in essential hypertension. Hypertension 1999, 33:575-580.
249. Fujimura N., Noma K., Hata T., et al. Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension. Clin. Pharmacol. Ther. 2012, 91:289-297.
250. Davies J.I., Band M., Morris A., Struthers A.D. Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes. Diabetologia 2004, 47:1687-1694.
251. Ghiadoni L., Taddei S., Virdis A. Hypertension and endothelial dysfunction: therapeutic approach. Curr. Vasc. Pharmacol. 2012, 10:42-60.
252. Shahin Y., Khan J.A., Samuel N., Chetter I. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials. Atherosclerosis 2011, 216:7-16.
253. Vanhoutte P.M., Gao Y. Beta blockers, nitric oxide, and cardiovascular disease. Curr. Opin. Pharmacol. 2013, 13:265-273.
254. Schwartz B.G., Jackson G., Stecher V.J., Campoli-Richards D.M., Kloner R.A. Phosphodiesterase type 5 inhibitors improve endothelial function and may benefit cardiovascular conditions. Am. J. Med. 2013, 126:192-199.
255. Masoura C., Pitsavos C., Aznaouridis K., Skoumas I., Vlachopoulos C., Stefanadis C. Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins. A systematic review and meta-analysis. Atherosclerosis 2011, 214:129-138.
256. Zhang L., Gong D., Li S., Zhou X. Meta-analysis of the effects of statin therapy on endothelial function in patients with diabetes mellitus. Atherosclerosis 2012, 223:78-85.
257. Kim K.H., Cho S.H., Yim Y.R., et al. Effects of low dose versus high dose statin therapy on the changes of endothelial function and carotid intima-media thickness in patients with variant angina. J.Cardiovasc Ultrasound 2013, 21:58-63.
258. Papathanassiou K., Naka K.K., Kazakos N., et al. Pioglitazone vs glimepiride: differential effects on vascular endothelial function in patients with type 2 diabetes. Atherosclerosis 2009, 205:221-226.
259. Van Bortel L.M., Spek J.J. Influence of aging on arterial compliance. J.Hum. Hypertens. 1998, 12:583-586.
260. Boutouyrie P., Lacolley P., Briet M., et al. Pharmacological modulation of arterial stiffness. Drugs 2011, 71:1689-1701.
261. Virdis A., Ghiadoni L., Qasem A.A., et al. Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients. Eur. Heart J. 2012, 33:1530-1538.
262. Ong K.T., Delerme S., Pannier B., et al. Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients. J.Hypertens. 2011, 29:1034-1042.
263. Kool M.J., Lustermans F.A., Breed J.G., et al. The influence of perindopril and the diuretic combination amiloride+hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients. J.Hypertens. 1995, 13:839-848.
264. Ait-Oufella H., Collin C., Bozec E., et al. Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice. J.Hypertens. 2010, 28:2336-2341.
265. Laurent S., Boutouyrie P., Vascular Mechanism C. Dose-dependent arterial destiffening and inward remodeling after olmesartan in hypertensives with metabolic syndrome. Hypertension 2014, 64:709-716.
266. Shahin Y., Khan J.A., Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis 2012, 221:18-33.
267. Vlachopoulos C., Terentes-Printzios D., Ioakeimidis N., et al. Beneficial effect of vardenafil on aortic stiffness and wave reflections. J.Clin. Pharmacol. 2012, 52:1215-1221.
268. Maki-Petaja K.M., Wilkinson I.B. Anti-inflammatory drugs and statins for arterial stiffness reduction. Curr. Pharm. Des. 2009, 15:290-303.
269. Schneider M.P., Delles C., Klingbeil A.U., et al. Effect of angiotensin receptor blockade on central haemodynamics in essential hypertension: results of a randomised trial. J.Renin Angiotensin Aldosterone Syst. 2008, 9:49-56.
270. Mackenzie I.S., McEniery C.M., Dhakam Z., Brown M.J., Cockcroft J.R., Wilkinson I.B. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension 2009, 54:409-413.
271. Ahmadi N., Hajsadeghi F., Gul K., et al. Vascular function measured by fingertip thermal reactivity is impaired in patients with metabolic syndrome and diabetes mellitus. J.Clin. Hypertens. (Greenwich) 2009, 11:678-684.
272. O'Rourke M.F., Hashimoto J. Arterial stiffness: a modifiable cardiovascular risk factor?. J.Cardiopulm. Rehabil. Prev. 2008, 28:225-237.
273. Dhakam Z., Yasmin McEniery CM., Burton T., Brown M.J., Wilkinson I.B. Acomparison of atenolol and nebivolol in isolated systolic hypertension. J.Hypertens. 2008, 26:351-356.
274. Wang J.G., Staessen J.A., Li Y., et al. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke 2006, 37:1933-1940.
275. Van Bortel L.M. What does intima-media thickness tell us?. J.Hypertens. 2005, 23:37-39.
276. Huang Y., Li W., Dong L., Li R., Wu Y. Effect of statin therapy on the progression of common carotid artery intima-media thickness: an updated systematic review and meta-analysis of randomized controlled trials. J.Atheroscler. Thromb. 2013, 20:108-121.
277. Migrino R.Q., Bowers M., Harmann L., Prost R., LaDisa J.F. Carotid plaque regression following 6-month statin therapy assessed by 3T cardiovascular magnetic resonance: comparison with ultrasound intima media thickness. J.Cardiovasc Magn. Reson 2011, 13:37.
278. Ainsworth C.D., Blake C.C., Tamayo A., Beletsky V., Fenster A., Spence J.D. 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke 2005, 36:1904-1909.
279. Kalashyan H., Shuaib A., Gibson P.H., et al. Single sweep three-dimensional carotid ultrasound: reproducibility in plaque and artery volume measurements. Atherosclerosis 2014, 232:397-402.
280. Pierce G.L., Beske S.D., Lawson B.R., et al. Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. Hypertension 2008, 52:72-79.
281. Tchernof A., Nolan A., Sites C.K., Ades P.A., Poehlman E.T. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 2002, 105:564-569.
282. Tumova E., Sun W., Jones P.H., Vrablik M., Ballantyne C.M., Hoogeveen R.C. The impact of rapid weight loss on oxidative stress markers and the expression of the metabolic syndrome in obese individuals. J.Obes. 2013, 2013:729515.
283. Tschoner A., Sturm W., Gelsinger C., et al. Long-term effects of weight loss after bariatric surgery on functional and structural markers of atherosclerosis. Obes. (Silver Spring) 2013, 21:1960-1965.
284. Hughes T.M., Althouse A.D., Niemczyk N.A., Hawkins M.S., Kuipers A.L., Sutton-Tyrrell K. Effects of weight loss and insulin reduction on arterial stiffness in the SAVE trial. Cardiovasc Diabetol. 2012, 11:114.
285. Figueroa A., Vicil F., Sanchez-Gonzalez M.A., et al. Effects of diet and/or low-intensity resistance exercise training on arterial stiffness, adiposity, and lean mass in obese postmenopausal women. Am. J. Hypertens. 2013, 26:416-423.
286. Kawamoto R., Kohara K., Katoh T., et al. Effect of weight loss on central systolic blood pressure in elderly community-dwelling persons. Hypertens. Res. 2014, 37:933-938.
287. Ryan A.S., Ge S., Blumenthal J.B., Serra M.C., Prior S.J., Goldberg A.P. Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women. J.Am. Geriatr. Soc. 2014, 62:607-614.
288. Espeland M.A., Lewis C.E., Bahnson J., et al. Impact of weight loss on ankle-brachial index and interartery blood pressures. Obes. (Silver Spring) 2014, 22:1032-1041.
289. Croymans D.M., Krell S.L., Oh C.S., et al. Effects of resistance training on central blood pressure in obese young men. J.Hum. Hypertens. 2014, 28:157-164.
290. Miyachi M. Effects of resistance training on arterial stiffness: a meta-analysis. Br. J. Sports Med. 2013, 47:393-396.
291. Karatzi K., Rontoyanni V.G., Protogerou A.D., et al. Acute effects of beer on endothelial function and hemodynamics: a single-blind, crossover study in healthy volunteers. Nutrition 2013, 29:1122-1126.
292. Wang Q., Liang X., Wang L., et al. Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials. Atherosclerosis 2012, 221:536-543.
293. Xaplanteris P., Vlachopoulos C., Pietri P., et al. Tomato paste supplementation improves endothelial dynamics and reduces plasma total oxidative status in healthy subjects. Nutr. Res. 2012, 32:390-394.
294. Gajendragadkar P.R., Hubsch A., Maki-Petaja K.M., Serg M., Wilkinson I.B., Cheriyan J. Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: a randomised controlled trial. PLoS One 2014, 9:e99070.
295. Vlachopoulos C.V., Alexopoulos N.A., Aznaouridis K.A., et al. Relation of habitual cocoa consumption to aortic stiffness and wave reflections, and to central hemodynamics in healthy individuals. Am. J. Cardiol. 2007, 99:1473-1475.
296. Vlachopoulos C., Hirata K., O'Rourke M.F. Effect of caffeine on aortic elastic properties and wave reflection. J.Hypertens. 2003, 21:563-570.
297. Wang T.J. New cardiovascular risk factors exist, but are they clinically useful?. Eur. Heart J. 2008, 29:441-444.
298. Blankenberg S., Zeller T., Saarela O., et al. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 2010, 121:2388-2397.
299. Zethelius B., Berglund L., Sundstrom J., et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N.Engl. J. Med. 2008, 358:2107-2116.